Thorne HealthTech Stock Forecast for 2023 - 2025 - 2030
Updated on 05/10/2024
Thorne HealthTech Fair Value Forecast for 2023 - 2025 - 2030
In the last two years, Thorne HealthTech's Price has decreased from $3.15 to $0.00 – a 100.00% drop. For next year, analysts predict Fair Value of $0.00, which would mean an increase of 100.00%. Over the next six years, experts predict that Thorne HealthTech's Fair Value will grow at a rate of 100.00%.
Thorne HealthTech Revenue Forecast for 2023 - 2025 - 2030
In the last year, Thorne HealthTech's Revenue has grown by 23.47%, rising from $185.25M to $228.73M. For the following year, the 0 analysts predict that Thorne HealthTech's Revenue will drop by 19.01%, reaching $185.25M. In 2030, the professionals' prediction is that THRN's Revenue will decrease by 10.54%, reaching $204.61M.
Thorne HealthTech EBITDA Forecast for 2023 - 2025 - 2030
In the last year, Thorne HealthTech has seen a decline in its EBITDA, from $15.77M to $11.82M – a 25.05% decrease. In the next year, analysts believe that EBITDA will reach $15.77M – an increase of 33.42%. For the next eight years, the forecast is for EBITDA to grow by 25.88%.
Thorne HealthTech EBIT Forecast for 2023 - 2025 - 2030
In the last year, Thorne HealthTech's EBIT has decreased by 47.00%, from $11.32M to $6.00M. For the next year, analysts predict that EBIT will reach $11.32M – an increase of 88.67%. Over the next eight years, experts believe that Thorne HealthTech's EBIT will grow at a rate of 85.82%.
Thorne HealthTech EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last two years, Thorne HealthTech's EPS has decreased from $0.21 to $0.00 – a 100.00% drop. For next year, analysts predict EPS of $0.00, which would mean an increase of 100.00%. Over the next six years, experts predict that Thorne HealthTech's EPS will grow at a rate of 100.00%.